Calidi Biotherapeutics Inc.

NYSE American: CLDI
Share price (12/20/24): $1.36
Market cap (12/20/24): $17.8 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Initial registration of new securities

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Removal from listing

Ownership Filter

Polar Asset Management Partners Inc.

Stewart Alan R.

Schoeneck James A

News Filter

Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer

Announces Proposed Public Offering

Reports Third Quarter 2024 Operating and Financial Results

Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

Material Disclosure, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC